期刊文献+

血透机制备透析液或置换液在连续性血液净化中的应用 被引量:6

下载PDF
导出
摘要 目的:探讨血透机制备透析液或置换液在连续血液净化中应用的可行性、实用性及其优点。方法:系统性回顾统计2007年12月~2010年2月在我院行连续血液净化治疗中利用血透机制备透析液或置换液69例,介绍透析液或置换液制备过程,检测其是否符合生理要求。结果:69例患者通过血透机制备透析液或置换液均达到应用要求,无并发症。结论:血透机制备透析液或置换液在连续血液净化中应用是可靠的,有一定的实用性,值得推广。
作者 王翠珍
出处 《皖南医学院学报》 CAS 2010年第6期471-473,共3页 Journal of Wannan Medical College
  • 相关文献

参考文献10

二级参考文献20

  • 1吴恒义,苏磊,宋新明,卢勇,白涛.创伤性成人呼吸窘迫综合征的诊治体会[J].中国危重病急救医学,1995,7(5):276-278. 被引量:26
  • 2于仲元.血液净化[M].北京:现代出版社,1994.417-419.
  • 3王笑云.急性肾衰竭现代诊疗[J].南京:江苏科技出版社,2001,(375).
  • 4Flynn CG. A review of continuous renal replacement therapy. Ir J Med Sci, 1994, 163(7):331-340
  • 5Van Bommel EF. Renal replacement therapy for acute renal failure on the intensive care unit: coming of age? Neth J Med, 2003, 61(8):239-248
  • 6Schetz M, Leblanc M, Murray PT. The Acute Dialysis Quality Initiative -part Ⅶ:fluid composition and management in CRRT. Adv Ren Replace Ther, 2002, 9(4):282-289
  • 7Davenport A. Dialysate and substitution fluids for patients treated by continuous forms of renal replacement therapy. Contrib Nephrol, 2001,(132):313 - 322
  • 8Van den Berghe. Insulin therapy for the critically ill patient.Clin Cornerstone, 2003,5(2) :56 - 63
  • 9Fortin MC, Amyot SL, Gendah D, et al. Scrum concentrations and clearances of folio acid and pyridoxal - 5 - phosphate during venovenous continuous renal replacement therapy. Intensive Care Med, 1999, 25(6):594- 8
  • 10Weber C, Stummvoll HK, Passon S, et al. Monocyte activation and humoral immune response to endotoxins in patients receiving on-line hemodiafiltration therapy. Int J Artif Organs, 1998, 21(6):335-340

共引文献206

同被引文献34

  • 1常平,宫桔云,陶少华,胡艳群,封志纯.两种置换液配方在连续性血液净化中的效果比较[J].中国血液净化,2005,4(1):45-47. 被引量:23
  • 21087例多器官功能障碍综合征临床流行病学调查[J].中国危重病急救医学,2007,19(1):2-6. 被引量:97
  • 3吴在德,吴肇汉.外科学[M].7版.北京:人民卫生出版社,2007:305-306.
  • 4Marshall JC,Cook DL,Christou NV,et al.Multiple organdysfunction score:a reliable descriptor of a complex clini-cal outcome[J].Crit Care Med,1995,23(10):1638-1652.
  • 5Tan HK,Uchino S,Bellomo R.The acid-base effects ofcontinuous hemofiltration with lactate or bicarbonate buff-ered replacement fluids[J].Int J Artif Organs,2003,26(6):477-483.
  • 6Schetz M,Leblanc M,Murray PT.The acute dialysis qualityinitiative-part VII:fluid composition and management inCRRT[J].Adv Ren Replace Ther,2002,9(4):282-289.
  • 7叶任高,陆再英.内科学[M].人民卫生出版社,2006:992-995.
  • 8Cariou A, Vinsonneau C, Dhainaut JF.Adjunctive therapies in sepsis; an evidence based review [.I]. Crit Care Med, 2004, 32: 562-570.
  • 9Ronco C, Bellomo R. Continuous renal replacement therapy: Evo- lution in technology and current nomenclature [J]. Kidney Int, 1998, 53 (supple 66): s160.
  • 10周海银,王晓刚,王兴勇.连续性血液净化治疗在多脏器功能障碍综合征的应用进展[J].现代医药卫生,2009,25(2):239-241. 被引量:16

引证文献6

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部